In a landscape dominated by constant evolution, the biopharmaceutical industry is experiencing a seismic shift of tectonic proportions. In an unprecedented departure from the traditional rural confines, major life sciences players are engaging in a high-stakes race to establish state-of-the-art manufacturing plants within the heart of thriving life sciences clusters. The stakes are high, and […]
Tag: Amgen
Sandoz Introduces First Interchangeable Denosumab Biosimilars in USA
Sandoz, the Swiss giant in the field of generic and biosimilar medicines, has made a significant move in the US market with the launch of Wyost and Jubbonti – the first interchangeable denosumab biosimilars approved by the Food and Drug Administration (FDA). These biosimilars have been approved to treat all indications of Amgen’s blockbuster medicines, […]
